GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod

Zacks10-10

GE Healthcare’s GEHC MIM Software recently announced the receipt of FDA clearance for its Monte Carlo Dosimetry, marking a significant advancement in theranostics. This innovative solution is designed...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2474665740?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UpEbnpQXp89kdVJQCodgsg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/fbb9903a8d1b847919d491b1319d2545","is_english":true,"pubTime":"2024-10-10 22:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2474665740","market":"us","top_or_hot":-1,"title":"GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod","media":"Zacks","content":"<div>\n<p>GE Healthcare’s GEHC MIM Software recently announced the receipt of FDA clearance for its Monte Carlo Dosimetry, marking a significant advancement in theranostics. This innovative solution is designed...</p>\n\n<a href=\"https://finance.yahoo.com/news/gehcs-mim-software-aid-radiation-140000509.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-10 22:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/gehcs-mim-software-aid-radiation-140000509.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GE Healthcare’s GEHC MIM Software recently announced the receipt of FDA clearance for its Monte Carlo Dosimetry, marking a significant advancement in theranostics. This innovative solution is designed...</p>\n\n<a href=\"https://finance.yahoo.com/news/gehcs-mim-software-aid-radiation-140000509.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4170","symbol_name":"电脑硬件、储存设备及电脑周边","start_time":0,"source_url":"https://finance.yahoo.com/news/gehcs-mim-software-aid-radiation-140000509.html","article_id":"2474665740","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UpEbnpQXp89kdVJQCodgsg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/fbb9903a8d1b847919d491b1319d2545"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474665740","pubTimestamp":1728568800,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The technology is pivotal in tailoring treatments specifically to the individual needs of patients, thereby maximizing therapeutic benefits and reducing potential risks associated with radiation therapy.Additionally, with this clearance, Monte Carlo Dosimetry via the Dose Planning Method is likely to be available for use with MIM SurePlan MRT, MIM Software’s comprehensive solution for automating and standardizing dosimetry in Theranostics. MIM SurePlan MRT provides enhanced visualization and treatment planning capabilities, enabling clinicians to assess and plan treatment more effectively. This platform allows healthcare providers to utilize complex dose calculations, enhancing the precision of patient-specific treatment plans.The FDA clearance of Monte Carlo Dosimetry is expected to significantly impact the field of nuclear medicine, as the demand for personalized treatment options continues to rise. This innovative tool aims to improve patient outcomes by providing precise radiation ","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4170":"电脑硬件、储存设备及电脑周边","LU1923623000.USD":"Natixis Thematics AI & Robotics Fund R/A USD","HOLX":"豪洛捷","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","LU1923622614.USD":"Natixis Thematics Meta R/A USD","BK4585":"ETF&股票定投概念","LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","BK4082":"医疗保健设备","GEHC":"GE HEALTHCARE TECHNOLOGIES INC","BK4588":"碎股","LU0689626769.HKD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (HKD) ACC","FUJIF":"FUJIFILM Holdings Corp.","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","FUJIY":"FUJIFILM Holdings Corp.","BFLY":"Butterfly Network Inc","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD"},"translate_title":"GEHC的MIM软件获得FDA最新批准，可帮助放射治疗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FUJIY":1,"GEHC":1,"BFLY":1,"FUJIF":0.9,"HOLX":0.9},"content_text":"GE Healthcare’s GEHC MIM Software recently announced the receipt of FDA clearance for its Monte Carlo Dosimetry, marking a significant advancement in theranostics. This innovative solution is designed to improve the precision of radiation dose calculations for personalized treatment plans in nuclear medicine, particularly for patients receiving radiopharmaceutical therapies.\nThe technology is pivotal in tailoring treatments specifically to the individual needs of patients, thereby maximizing therapeutic benefits and reducing potential risks associated with radiation therapy.\nMore on Monte Carlo Dosimetry\nMonte Carlo Dosimetry employs advanced modeling techniques to provide accurate dose assessments for patients undergoing radiopharmaceutical therapy. By simulating the interactions of radiation with matter, the Monte Carlo method allows for more precise modeling of how different tissues absorb and respond to radiation. The precision of the Monte Carlo method is vital for ensuring that patients receive the correct amount of radiation, thereby minimizing the likelihood of side effects and maximizing treatment efficacy.\nAdditionally, with this clearance, Monte Carlo Dosimetry via the Dose Planning Method is likely to be available for use with MIM SurePlan MRT, MIM Software’s comprehensive solution for automating and standardizing dosimetry in Theranostics. MIM SurePlan MRT provides enhanced visualization and treatment planning capabilities, enabling clinicians to assess and plan treatment more effectively. This platform allows healthcare providers to utilize complex dose calculations, enhancing the precision of patient-specific treatment plans.\nThe FDA clearance of Monte Carlo Dosimetry is expected to significantly impact the field of nuclear medicine, as the demand for personalized treatment options continues to rise. This innovative tool aims to improve patient outcomes by providing precise radiation dose calculations tailored to each patient's unique circumstances.\nOther Developments in the Medical Imaging Space\nAs the field of medical imaging continues to evolve, several key players are making significant strides in developing innovative solutions that enhance diagnostic and therapeutic capabilities.\nHologic, Inc. HOLX has expanded its reach in breast health through innovative imaging technologies. The company is advancing its Brevera Breast Biopsy System, which improves the accuracy and speed of breast biopsies, allowing healthcare providers to deliver faster and more comfortable diagnostic services.\nHologic is also integrating artificial intelligence (AI) into its mammography systems, enhancing the ability of radiologists to identify abnormalities quickly. The company is also focusing on global expansion, targeting European and Asian markets for its advanced mammography, diagnostics, and surgical equipment, further strengthening its leadership in the breast imaging sector.\nFUJIFILM Holdings Corporation FUJIY continues to make advancements in AI-driven diagnostic imaging with the development of the ReiLi AI platform, which enhances image analysis for CT and X-ray scans. This technology helps to improve the speed and accuracy of diagnostics in critical care environments.\nFujifilm has also unveiled new MRI platforms that provide high-resolution imaging with reduced scan times, benefiting patients in oncology, neurology and musculoskeletal care. The company has also advanced its 3D imaging technologies for use in surgical planning, enabling surgeons to visualize internal structures more clearly, thus improving the precision of minimally invasive procedures.\nButterfly Network, Inc. BFLY is emerging as a game-changer in the medical imaging industry with its handheld ultrasound technology. The company's portable ultrasound device utilizes patented Ultrasound-on-Chip technology, which allows for easy integration into clinical workflows. This breakthrough enables healthcare practitioners to perform whole-body imaging using a device that is both affordable and accessible.\nBy democratizing access to ultrasound technology, Butterfly Network is enhancing diagnostic capabilities in settings that previously lacked advanced imaging tools, ultimately improving healthcare delivery in both developed and under-resourced areas.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nHologic, Inc. (HOLX) : Free Stock Analysis Report\nFujifilm Holdings Corp. (FUJIY) : Free Stock Analysis Report\nButterfly Network, Inc. (BFLY) : Free Stock Analysis Report\nGE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2474665740"}